CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Emery, P. [1 ]
van Hoogstraten, H. [2 ]
Mangan, E. K. [3 ]
van Adelsberg, J. [3 ]
Fan, C. [2 ]
Kivitz, A. [4 ]
Pinheiro, G. da R. C. [5 ]
Huizinga, T. [6 ]
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] Sanofi, Bridgewater, MA USA
[3] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[4] Altoona Ctr Clin Res, Duncansville, PA USA
[5] Univ Estado Rio De Janeiro, Discipline Rheumatol, Rio De Janeiro, Brazil
[6] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4415
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0178
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [1] CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Emery, Paul
    van Hoogstraten, Hubert
    Mangan, Erin K.
    van Adelsberg, Janet
    Fan, Chunpeng
    Kivitz, Alan
    Pinheiro, Geraldo da R. C.
    Huizinga, Tom W.
    RHEUMATOLOGY, 2017, 56 : 140 - 141
  • [2] CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI- CYCLIC CITRULLINATED PEPTIDE AUTOANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Emery, P.
    Van Hoogstraten, H.
    Mangan, E.
    Kivitz, A.
    Pinheiro, G.
    Huizinga, T.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 29 - 30
  • [3] Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
    Mohamad, Wan Majdiah Wan
    Jia, Soh Ke
    Ghazali, Wan Syamimee Wan
    Taib, Haslina
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2018, 34 (04) : 907 - 912
  • [4] The role of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Diagnosis of Rheumatoid Arthritis
    Mobini, M.
    Kashi, Z.
    Mahdavi, M. R.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2010, 12 (02) : 100 - 103
  • [5] Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis
    Chang, Pi-Yueh
    Yang, Cheng-Tao
    Cheng, Ching-Hui
    Yu, Kuang-Hui
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 880 - 886
  • [6] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY AND RHEUMATOID FACTOR AND THE RELATIONSHIP BETWEEN PERIODONTITIS AND RHEUMATOID ARTHRITIS
    Bolyarova-Konova, Theodora Nikolaeva
    Stefanov, Lyubomir Deyanov
    Kolarov, Zlatimir Gospodinov
    Grozdanova, Radoslava Emilova
    Nikolova, Maria Hristianova
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2022, 75 (03): : 451 - 457
  • [7] Clinical Significance of Combined Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Assays in Rheumatoid Arthritis Diagnosis
    Cao, Qingmei
    Wang, Yanfeng
    Jing, Yuanyuan
    ARCHIVES OF RHEUMATOLOGY, 2015, 30 (02): : 104 - 108
  • [8] Clinical Significance of Anti-Cyclic Citrullinated Peptide Antibodies and IgM Rheumatoid Factor in Rheumatoid Arthritis Patients
    Seo, Soyeon
    Lee, Jisoo
    Kang, Eun-Suk
    EWHA MEDICAL JOURNAL, 2005, 28 (02): : 87 - 92
  • [9] Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients
    Sulaiman, Farah Nadiah
    Wong, Kah Keng
    Ahmad, Wan Aireene Wan
    Ghazali, Wan Syamimee Wan
    MEDICINE, 2019, 98 (12)
  • [10] Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis
    Ueda-Hayakawa, Ikuko
    Hasegawa, Minoru
    Kumada, Sayako
    Tanaka, Chihiro
    Komura, Kazuhiro
    Hamaguchi, Yasuhito
    Takehara, Kazuhiko
    Fujimoto, Manabu
    RHEUMATOLOGY, 2010, 49 (11) : 2135 - 2139
12345